29 Jul 2017

Takeda Reports 1st Quarter FY2017 Results

(ME NewsWire)-- Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth of 6.6% led by Takeda's Growth Drivers Underlying Revenue grew +6.6% with growth across all regions (U.S. +13.5%, Japan +1.6%, Europe & Canada +4.6%, Emerging Markets +6.0%). Takeda's Growth Drivers (GI, Oncology, CNS and Emerging Markets) maintained their strong momentum to deliver growth of +14.7%. GI (Gastroenterology) +23.2%, led by continued success of ENTYVIO® and TAKECAB® Oncology +12.2%, driven by NINLARO®,......

Continue Reading

27 Jul 2017

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and HUMIRA® 

  • First patient enrolled into VOLTAIRE-X; an interchangeability study designed to assess whether BI 695501 is interchangeable with Humira®1
  • First study in the U.S. to investigate an interchangeability designation for an adalimumab biosimilar candidate
  • BI 695501 is currently under review by regulatory authorities2


Continue Reading

24 Jul 2017

Data Published in The Lancet Shows High Efficacy at 96 Weeks for First Investigational Two-Drug, Long-Acting Injectable HIV Regimen

- Long-term data from the Phase 2b LATTE-2 study demonstrated comparable antiviral activity to daily, oral 3-drug combination -

- Data presented as an oral late breaker at the 9th International AIDS Society Conference,"...

Continue Reading

24 Jul 2017

Johnson & Johnson Announces Encouraging First-in-Human Clinical Data for Investigational HIV Preventive Vaccine 

In Phase 1/2a APPROACH study, HIV-1 antibody response observed in all healthy volunteers

Mosaic-based vaccine regimen is designed to elicit an immune response against a wide variety of HIV subtypes prevalent worldwide


Continue Reading

24 Jul 2017

People with idiopathic pulmonary fibrosis (IPF) reveal high burden of disease in new survey 

• 61% of IPF patients are worried or extremely worried about experiencing an acute IPF exacerbation1

• Survey underlines the importance of appropriate support and coping mechanisms for patients living"...

Continue Reading

22 Jul 2017

The Paradise Foundation Launches First Overseas Conservation Program in Africa 

(ME NewsWire)-- The Paradise Foundation, a not-for-profit environmental conservation organization in China, announced its first overseas conservation program in Africa today. The announcement was made during the Foundation delegates’ visit"...

Continue Reading

21 Jul 2017

AHF KENYA, NACC, Nairobi City County and Partners Hosts Street Dance Competition: Base Yangu, Dunda Yangu Grand Finale!

(ME NewsWire)-- AHF Kenya, in collaboration with NACC, Nairobi City County, and a host of partners will today light up Nairobi with the grand finale of Base Yangu, Dunda Yangu; under the theme “Street Dance With A Difference”. Base Yangu, Dunda Yangu translated as My Base, My Dance, is a street dance project which targets young people in three slum areas of Nairobi, namely, Mathare, Kibera and Mukuru. The program is part of AHF’s creative responses to address the disproportionately high spate of new HIV infections among young people, through the infusion of dance and open forum discussions that focus on HIV Prevention, Stigma......

Continue Reading
Found articles: - Pages  
Contact US | Powered by - All Rights Reserved